Non‐canonical Raf‐1/p70S6K signalling in non–small‐cell lung cancer

Lung cancer is the leading cause of cancer‐related death globally, with non–small‐cell lung cancer (NSCLC) being the predominant subtype. Overall survival remains low for NSCLC patients, and novel targets are needed to improve outcome. Raf‐1 is a key component of the Ras/Raf/MEK signalling pathway,...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Zhixin, Ye, Bingwei, Zhao, Shuang, Li, Xin, Li, Lei, Mo, Ximing, Li, Weimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815804/
https://www.ncbi.nlm.nih.gov/pubmed/31541523
http://dx.doi.org/10.1111/jcmm.14636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815804/
https://www.ncbi.nlm.nih.gov/pubmed/31541523
http://dx.doi.org/10.1111/jcmm.14636

Ejemplares similares